The Project for Emerging Nanotechnologies at the Woodrow Wilson International Center for Scholars commissioned a poll that found the average American doesn’t really know what’s going on in the nanotechnology field. It immediately occurred to me the best way to get the word out on these nano-advances was to write about some here.
First off, nano is just a metric prefix. Most people are aware of kilo-, centi-, milli- in common measures of mass or distance. Just like a millimetre is 1/1,000th of a metre, a nanometre is 1/1, 000, 000, 000th of a metre–very short. A bond between two atoms is on the order of 0.1 – 0.3 nm. So, when you are working on the nano-scale you are working with individual molecules or small assemblies of molecules that range from a few to several hundred nanometres in size.
Now, the big thing many people working in the field like to talk about is the potential for nanocomputers, where individual molecules are used to carry out the computing functions instead of the currently microscopic components of your computer today. I think that’s kind of lame.
Personally, I think the potential for nanoparticles to deliver drugs is much more exciting. For instance, in a recent report, researchers at the University of Texas write that by attaching insulin-containing liposomes (it’s like a small bag made of fat carrying insulin) to a blood sugar-sensing protein called concanavalin, this nanostructure can mimic the function of the pancreas. They call it a smart particle, and it works because when it encounters glucose in the blood, the liposomes are replaced on the protein by the glucose and the insulin inside the liposomes is then released. So, the more glucose there is in the blood, the more insulin gets released.
This study demonstrates that such a system works in rats, although they haven’t developed a version that could be put into clinical trials on humans as of yet. Still, the potential benefits for diabetics would be enormous, inhaling a dose of these nanostructures daily replacing the multiple pricks and needles of blood testing and insulin injections.
And medically engineered nanoparticles can be used to do more than regulate doses of pharmaceuticals. Earlier this year, researchers at enGene Inc. presented results from their studies aimed at using nanoparticles to introduce the insulin gene to patients with juvenile diabetes. Using this technology, the gene is incoporated into specific cells in the stomach that would then take over the insulin production. This treatment would eliminate the need for injections and would be more responsive to the spikes in blood sugar levels that occur after eating a meal.
So, now if some polling agency phones up and asks if you know of any applications of nanotechnology, you can say that you most certainly do!


